ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,426Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 143

$527K Total Retail Price of All Prescriptions

Rank: 24 out of 143

503 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 4,994 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
SIMVASTATIN 334 230 1 2
HYDROCODONE-ACETAMINOPHEN 308 207 S3 2 20
LISINOPRIL 305 226 3 1
AMLODIPINE BESYLATE 219 184 4 4
OMEPRAZOLE 206 105 5 5
FUROSEMIDE 181 139 6 6
GABAPENTIN 181 98 6 18
LEVOTHYROXINE SODIUM 166 148 8 3
SYNTHROID 153 123 9 24
METFORMIN HCL 130 97 10 8
METOPROLOL TARTRATE 124 112 11 12
ZOLPIDEM TARTRATE 123 91 12 13
CRESTOR 109 72 13 17
TRAMADOL HCL 102 69 14 16
SPIRIVA 98 38 15 38
CARVEDILOL 93 86 16 22
CITALOPRAM HBR 88 63 17 25
NEXIUM 87 40 18 32
METOPROLOL SUCCINATE 87 76 18 14
LOSARTAN POTASSIUM 84 55 20 19
ATORVASTATIN CALCIUM 79 54 21 7
ESCITALOPRAM OXALATE 76 58 22 46
FLUTICASONE PROPIONATE 76 62 22 37
CLOPIDOGREL 72 54 24 33
ADVAIR DISKUS 71 34 25 42
WARFARIN SODIUM 68 49 26 15
SERTRALINE HCL 67 47 27 23
HYDROCHLOROTHIAZIDE 64 28 28 10
ATENOLOL 64 54 28 11
DONEPEZIL HCL 63 63 30 36
PROAIR HFA 61 0 31 48
RANITIDINE HCL 60 40 32 41
KLOR-CON M20 59 48 33 69
PANTOPRAZOLE SODIUM 58 34 34 43
PRAVASTATIN SODIUM 56 54 35 9
LYRICA 54 26 36 96
PREDNISONE 52 39 37 35
TAMSULOSIN HCL 52 50 37 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.